These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3924605)

  • 21. Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Sadoff JC; Fürer E
    Microb Pathog; 1989 Jan; 6(1):75-80. PubMed ID: 2733597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
    Gonggrijp R; Mullers WJ; van Boven CP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.
    Priebe GP; Meluleni GJ; Coleman FT; Goldberg JB; Pier GB
    Infect Immun; 2003 Mar; 71(3):1453-61. PubMed ID: 12595463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.
    Cryz SJ; Sadoff JC; Fürer E; Germanier R
    J Infect Dis; 1986 Oct; 154(4):682-8. PubMed ID: 3091708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological studies of an artificial antigen with specificity of a common polysaccharide antigen of Pseudomonas aeruginosa.
    Makarenko TA; Kocharova NA; Edvabnaya LS; Tsvetkov YE; Kholodkova EV; Knirel YA; Backinowsky LV; Kochetkov NK; Stanislavsky ES
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):251-6. PubMed ID: 7506094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection by vaccination against Pseudomonas infection after thermal injury.
    Markley K; Smallman E
    J Bacteriol; 1968 Oct; 96(4):867-74. PubMed ID: 4971892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.
    Pier GB; Meluleni G; Goldberg JB
    Infect Immun; 1995 Aug; 63(8):2818-25. PubMed ID: 7542632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine in a burned mouse model.
    Neely AN; Bhattacharjee AK; Babcock GF; Holder IA; Cross AS
    J Burn Care Rehabil; 2002; 23(5):333-40. PubMed ID: 12352135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the Shigella serotype D (S. sonnei) O polysaccharide and the enterobacterial R1 lipopolysaccharide core by use of mouse monoclonal antibodies.
    Viret JF; Bruderer U; Lang AB
    Infect Immun; 1992 Jul; 60(7):2741-7. PubMed ID: 1612742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigens.
    Stanislavsky ES; Makarenko TA; Kholodkova EV; Lugowski C
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):139-45. PubMed ID: 9271164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-protection by Pseudomonas aeruginosa polysaccharides.
    Pier GB
    Infect Immun; 1982 Dec; 38(3):1117-22. PubMed ID: 6185423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum.
    Drake D; Montie TC
    Can J Microbiol; 1987 Sep; 33(9):755-63. PubMed ID: 3121159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of lipopolysaccharide-induced protection against pseudomonas sepsis in granulocytopenic mice.
    Tegtmeier BR; Andersen BR
    Rev Infect Dis; 1983; 5 Suppl 5():S963-70. PubMed ID: 6419318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.